D7632C00001 TROPION-Lung10: A Phase III, Randomised, Open-label, Global Study of Datopotamab Deruxtecan (Dato-DXd) in Combination With Rilvegostomig (AZD2936) or Rilvegostomig Monotherapy VersusPembrolizumab Monotherapy for the First-line Treatment of Participants With Locally-advanced or Metastatic Non-squamous NSCLC With High PD-L1 Expression (TC = 50%) and Without Actionable Genomic Alterations (TROPION-Lung10)

Objective

Clinical Trial Details

Principal Investigator(s)

Benjamin Solomon, MD

Clinical Trial Categories

• Cancer
• Lung Cancer

Contact

Medical Oncology Research Coordinators at 605-322-3295
or medoncresearch@avera.org